Ariel Cerenzie, O.D., FAAO, FSLS
Dr. Ariel Cerenzie was born and raised in a small town in West Texas. She graduated with Magna Cum Laude honors from Texas A&M University where she received a Bachelor of Science in Nutritional Sciences. While at A&M, she enjoyed competing with the Texas A&M Waterski Team.
After completing her bachelors, she graduated Magna Cum Laude from the University of Houston College of Optometry. During optometry school, she was selected for the university’s Dry Eye Specialty Clinic, which provided her with extensive education and clinical management of dry eye disease.
Upon graduating, Dr. Cerenzie completed an additional year of residency training in cornea and contact lenses at the University of Missouri in St. Louis. She specializes in fitting patients with keratoconus, post-corneal grafts, and other corneal degenerations/dystrophies, as well as patients that have high astigmatism, large prescriptions, or patients that just want better vision through contact lenses.
Dr. Cerenzie has earned a fellowship in both the American Academy of Optometry and the Scleral Lens Education Society. She is also a member of the National Keratoconus Foundation.
Dr. Cerenzie enjoys traveling, going to the gym, being outdoors, sipping wine on her porch, and spending time with her husband, James, and pup, Otis.
A Passion For Myopia Control
During Dr. Cerenzie’s residency, she developed a passion for myopia control. Myopia, or near-sightedness, is becoming an epidemic in America. Research shows that as the amount of near-sightedness increases, the risk of developing retinal detachments (where the retina becomes detached from the back of the eye), glaucoma, myopic maculopathy (a disorder of our central vision) and early cataracts also increases. The increasing near-sightedness is a result of the orbit, or the eye, abnormally growing which can result in these blinding diseases. In addition, uncorrected near-sightedness can cause learning difficulties in the classroom.
Dr. Cerenzie works extensively with FDA-approved contact lenses, called orthokeratology, that slows the progression of myopia by 40-50% over the child’s lifetime. That means that myopia therapy can significantly change your child’s risk of developing blinding eye conditions. For example, the risk of developing a retinal detachment decreases from 22 times to just 3 times the risk, or 41 times the risk for developing myopic maculopathy to just 2 times the risk.
The contact lens is approved for nighttime wear and is only worn while sleeping. During myopia therapy, the contact lens causes the tear film of the child’s eyes to temporarily reshape the cornea while the child sleeps. This reshaping creates an environment that will slow the progression of near-sightedness. A bonus is that the child will have no need for glasses or contacts during the day as long as the lens is worn nightly.
There is no age limit for myopia control and Dr. Cerenzie has experience with patients as young as 5 or 6 years old that begin therapy. Dr. Cerenzie is accepting myopia therapy patients daily and would love to determine if your child is a good candidate for treatment.